Why We Need an Independent Comparative Effectiveness Institute
Data From Studies of Pfizer Neurontin Drug May Have Been Skewed
Bloomberg – November 11, 2009
Researchers say trials of Pfizer Inc.’s Neurontin epilepsy treatment for uses that were not yet approved may have been skewed to emphasize favorable results.
No comments yet.